Evidence map›Paper›PMID 41233305›Full record

ArticleNature communications2025

Structural Insights into De Novo Promoter Escape by Mycobacterium tuberculosis RNA Polymerase.

Joshua Brewer, Madeleine Delbeau, Winston Bates Zoullas, Seth A Darst, Elizabeth A Campbell

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joshua BrewerLaboratory of Molecular Pathogenesis, The Rockefeller University, New York, NY, USA.ORCID http://orcid.org/0000-0002-6737-7828
Madeleine DelbeauLaboratory of Molecular Pathogenesis, The Rockefeller University, New York, NY, USA.
Winston Bates ZoullasLaboratory of Molecular Pathogenesis, The Rockefeller University, New York, NY, USA.ORCID http://orcid.org/0009-0009-6647-8916
Seth A DarstLaboratory of Molecular Biophysics, The Rockefeller University, New York, NY, USA.ORCID http://orcid.org/0000-0002-8241-3153
Elizabeth A CampbellLaboratory of Molecular Pathogenesis, The Rockefeller University, New York, NY, USA. campbee@rockefeller.edu.ORCID http://orcid.org/0000-0002-1332-128X

Funding

Structure, function, and regulation of the bacterial transcription cycleR35GM118130 · NIGMS · ROCKEFELLER UNIVERSITY · PI DARST, SETH A. · 2016 to 2025
$8.9M
Structural and functional studies of the mycobacterial transcription cycleR35GM151879 · NIGMS · ROCKEFELLER UNIVERSITY · PI ELIZABETH A CAMPBELL · 2024 to 2026
$1.4M
NIGMS NIH HHS R35 GM118130NIGMS NIH HHS R35 GM151879
6 · The paper itself

Abstract

Transcription in bacteria is a multi-step process. In the first step, contacts between RNA polymerase and the promoter DNA must be established for transcription initiation to begin, but then these contacts must be broken for the enzyme to transition into the elongation phase. Single-molecule and biochemical observations report that promoter escape is a highly regulated and sometimes rate-limiting step in the transcription cycle; however, the structural mechanisms of promoter escape remain obscure. Promoter escape also serves as the target for the clinically important antibiotic rifampicin, used to treat tuberculosis. Here, we present seven distinct intermediates showing the structural details of M. tuberculosis RNA polymerase initial transcribing complexes and promoter escape, using a de novo cryo-electron microscopy approach. We describe the structural rearrangements that RNA polymerase undergoes to clear the promoter, including those required to release the initiation factor, σ, providing a structural account for decades of biochemical observations. These structures and supporting biochemistry provide a model of promoter escape, a universal step in the transcription cycle, with conformations that may be used to develop Rifampicin alternatives.

Indexed as

Bacterial ProteinsDNA-Directed RNA PolymerasesMycobacterium tuberculosisPromoter Regions, GeneticCryoelectron MicroscopyDNA, BacterialModels, MolecularRifampinSigma FactorTranscription, GeneticBacterial ProteinsDNA, BacterialDNA-Directed RNA PolymerasesRifampinSigma Factor

Identifiers

PMID41233305
PMCPMC12615793

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.